Quanterix Corporation Releases Operating Results for Second Quarter 2019
$13.5M revenues, 57% Q2 YOY revenue growth and 520 bps of gross margin increase BILLERICA, Mass.–(BUSINESS WIRE)–Quanterix Corporation (NASDAQ: QTRX),…
Pharmaceuticals, Biotechnology and Life Sciences
$13.5M revenues, 57% Q2 YOY revenue growth and 520 bps of gross margin increase BILLERICA, Mass.–(BUSINESS WIRE)–Quanterix Corporation (NASDAQ: QTRX),…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for the…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Magenta Therapeutics (NASDAQ: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of stem…
Proprietary technology platform to help expedite clinical trials of innovative cannabinoid-based product candidates SASKATOON, Saskatchewan–(BUSINESS WIRE)–ZYUS Life Sciences Inc.…
Gilead Canada recognizes the Ontario Ministry of Health for providing access to new treatment for people living with HIV According…
– Successfully completed follow-on public offering raising approximately $40 million in gross proceeds – – Patient enrollment in Phase 3…
BOSTON–(BUSINESS WIRE)–Rodin Therapeutics, a clinical-stage biopharmaceutical company developing novel therapies for synaptopathies, today announced the appointment of veteran investment professional…
CHICAGO–(BUSINESS WIRE)–Emalex Biosciences Inc., a biopharmaceutical company developing innovative therapies for patients with neurological and psychiatric conditions, today announced the…
BOSTON–(BUSINESS WIRE)–$KRTX–Karuna Therapeutics, Inc. (Nasdaq: KRTX), a clinical-stage biopharmaceutical company primarily focused on developing novel therapies to address disabling neuropsychiatric…
LONDON–(BUSINESS WIRE)–#Biotechnology–The global fallopian tube cancer therapeutics market is expected to post a CAGR of more than 8% during the…